Progress in measles control--Zambia, 1999-2004 - PubMed
- ️Sat Jan 01 2005
. 2005 Jun 17;54(23):581-4.
- PMID: 15959454
Free article
Progress in measles control--Zambia, 1999-2004
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2005.
Free article
Abstract
Zambia, a southern African country with estimated population of 11.6 million in 2005, reported 1,698-23,518 measles cases annually during 1991-1999. During that period, measles was considered one of the five major causes of morbidity and mortality among children aged <5 years. During 1999-2004, the challenge of controlling measles led Zambia to try several strategies in succession. In addition to a single dose of measles vaccine offered at age 9 months through routine services, in 1999, measles supplemental immunization activities (SIAs) targeting children aged 9 months-4 years were held in four urban centers. Those activities were followed in 2000 by a subnational measles SIA targeting children aged 9 months-4 years in approximately half of the country's 72 districts. In 2003, Zambia adopted a strategy of accelerated measles control that included strengthening routine vaccination, providing a second opportunity for measles immunization for all children, and conducting case-based surveillance. As part of this strategy, a nationwide measles SIA targeting all children aged 6 months-14 years was conducted in 2003. This report summarizes progress in measles control in Zambia during 1999--2004, as measured through surveillance data, which demonstrates a marked reduction in measles transmission after the 2003 SIA.
Similar articles
-
Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2001 Jun 22;50(24):513-6. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11432675
-
Progress in measles control--Kenya 2002-2007.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2007 Sep 21;56(37):969-72. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17882128
-
Progress in measles control--Nepal, 2000-2006.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2007 Oct 5;56(39):1028-31. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17914331
-
Progress toward measles elimination in Germany.
Hellenbrand W, Siedler A, Tischer A, Meyer C, Reiter S, Rasch G, Teichmann D, Santibanez S, Altmann D, Claus H, Kramer M. Hellenbrand W, et al. J Infect Dis. 2003 May 15;187 Suppl 1:S208-16. doi: 10.1086/368046. J Infect Dis. 2003. PMID: 12721915 Review.
-
The unfinished measles immunization agenda.
Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S. Strebel P, et al. J Infect Dis. 2003 May 15;187 Suppl 1:S1-7. doi: 10.1086/368226. J Infect Dis. 2003. PMID: 12721885 Review.
Cited by
-
Malama K, Tichacek A, Kelly H, Parker R, Inambao M, Sharkey T, Wall KM, Kilembe W, Price MA, Fast P, Priddy F, Allen S. Malama K, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2066426. doi: 10.1080/21645515.2022.2066426. Epub 2022 Apr 21. Hum Vaccin Immunother. 2022. PMID: 35446726 Free PMC article. Clinical Trial.
-
Suppression of human immunodeficiency virus type 1 viral load during acute measles.
Moss WJ, Scott S, Ndhlovu Z, Monze M, Cutts FT, Quinn TC, Griffin DE. Moss WJ, et al. Pediatr Infect Dis J. 2009 Jan;28(1):63-5. doi: 10.1097/INF.0b013e318184eed2. Pediatr Infect Dis J. 2009. PMID: 19057456 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials